117 related articles for article (PubMed ID: 30207441)
1. Evaluation of New Antibacterial Drugs and their Combinations in a Murine Model to Identify Short Duration Alternative Chemotherapy for Leprosy.
Arumugam S; Joseph P; Ponnaiya J; Richard J; Das M; Chaitanya VS; Ebenezer M
Indian J Lepr; 2016; 88(3):159-76. PubMed ID: 30207441
[TBL] [Abstract][Full Text] [Related]
2. Bactericidal activities of combinations of new drugs against Mycobacterium leprae in nude mice.
Ji B; Perani EG; Petinom C; Grosset JH
Antimicrob Agents Chemother; 1996 Feb; 40(2):393-9. PubMed ID: 8834886
[TBL] [Abstract][Full Text] [Related]
3. Combination of rifapentine-moxifloxacin-minocycline (PMM) for the treatment of leprosy.
Ji B; Grosset J
Lepr Rev; 2000 Dec; 71 Suppl():S81-7. PubMed ID: 11201894
[TBL] [Abstract][Full Text] [Related]
4. Bactericidal activities of single or multiple doses of various combinations of new antileprosy drugs and/or rifampin against M. leprae in mice.
Ji B; Perani EG; Petinon C; Grosset JH
Int J Lepr Other Mycobact Dis; 1992 Dec; 60(4):556-61. PubMed ID: 1338596
[TBL] [Abstract][Full Text] [Related]
5. Bactericidal activities of HMR 3647, moxifloxacin, and rifapentine against Mycobacterium leprae in mice.
Consigny S; Bentoucha A; Bonnafous P; Grosset J; Ji B
Antimicrob Agents Chemother; 2000 Oct; 44(10):2919-21. PubMed ID: 10991891
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of anti-bacterial activity of Rifapentine, Clarithromycin, Minocycline, Moxifloxacin, Ofloxacin and their combinations in Murine Model of Rifampicin Resistant Leprosy.
Joseph P; Ponnaiya J; Das M; Chaitanya VS; Arumugam S; Ebenezer M
Indian J Lepr; 2016; 88(3):147-58. PubMed ID: 30207440
[TBL] [Abstract][Full Text] [Related]
7. Experimental evaluation of possible new short-term drug regimens for treatment of multibacillary leprosy.
Banerjee DK; McDermott-Lancaster RD; McKenzie S
Antimicrob Agents Chemother; 1997 Feb; 41(2):326-30. PubMed ID: 9021187
[TBL] [Abstract][Full Text] [Related]
8. Bactericidal activity of single dose of clarithromycin plus minocycline, with or without ofloxacin, against Mycobacterium leprae in patients.
Ji B; Jamet P; Perani EG; Sow S; Lienhardt C; Petinon C; Grosset JH
Antimicrob Agents Chemother; 1996 Sep; 40(9):2137-41. PubMed ID: 8878595
[TBL] [Abstract][Full Text] [Related]
9. Bactericidal activity of a single-dose combination of ofloxacin plus minocycline, with or without rifampin, against Mycobacterium leprae in mice and in lepromatous patients.
Ji B; Sow S; Perani E; Lienhardt C; Diderot V; Grosset J
Antimicrob Agents Chemother; 1998 May; 42(5):1115-20. PubMed ID: 9593137
[TBL] [Abstract][Full Text] [Related]
10. Further study of the effectiveness of single doses of clarithromycin and minocycline against Mycobacterium leprae in mice.
Xiong JH; Ji B; Perani EG; Pétinon C; Grosset JH
Int J Lepr Other Mycobact Dis; 1994 Mar; 62(1):37-42. PubMed ID: 8189087
[TBL] [Abstract][Full Text] [Related]
11. Post-exposure prophylaxis (PEP) efficacy of rifampin, rifapentine, moxifloxacin, minocycline, and clarithromycin in a susceptible-subclinical model of leprosy.
Lenz SM; Collins JH; Ray NA; Hagge DA; Lahiri R; Adams LB
PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008583. PubMed ID: 32936818
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a new fixed duration (12 weeks) multi-drug regimen of bactericidal drugs in multibacillary leprosy.
Tejasvi T; Khaitan BK; Khanna N; Pandhi RK; Singh MK
Indian J Lepr; 2006; 78(4):329-37. PubMed ID: 17402345
[TBL] [Abstract][Full Text] [Related]
13. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
Mane I; Cartel JL; Grosset JH
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595
[TBL] [Abstract][Full Text] [Related]
14. Newer drugs in leprosy.
Grosset JH
Int J Lepr Other Mycobact Dis; 2001 Jun; 69(2 Suppl):S14-8. PubMed ID: 11757174
[TBL] [Abstract][Full Text] [Related]
15. An experimental study to evaluate the bactericidal activity of ofloxacin against an established Mycobacterium leprae infection.
Banerjee DK; McDermott-Lancaster RD
Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):410-5. PubMed ID: 1474279
[TBL] [Abstract][Full Text] [Related]
16. Combined chemotherapy trials with regimens containing ofloxacin and rifampicin for multibacillary leprosy patients.
Sampoonachot P; Bundit C; Kuhacharoen N; Peerapakorn S; Kampirapap K; Poomlek A; Bampenyu S; Tiasiri S; Rungruang S; Surasondhi S; Supanwanit S; Wiriyawipart S
J Med Assoc Thai; 1996 Apr; 79(4):210-7. PubMed ID: 8708505
[TBL] [Abstract][Full Text] [Related]
17. Long term follow-up results of 1 year MDT in MB leprosy patients treated with standard MDT + once a month Minocycline and Ofloxacin.
Katoch K; Katoch VM; Natarajan M; Gupta UD; Sharma VD; Singh HB
Indian J Lepr; 2008; 80(4):331-44. PubMed ID: 20329382
[TBL] [Abstract][Full Text] [Related]
18. Clinical trial of pefloxacin and ofloxacin in the treatment of lepromatous leprosy.
Grosset JH; Ji BH; Guelpa-Lauras CC; Perani EG; N'Deli LN
Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):281-95. PubMed ID: 2198315
[TBL] [Abstract][Full Text] [Related]
19. The activity of several newer antimicrobials against logarithmically multiplying M. leprae in mice.
Burgos J; de la Cruz E; Paredes R; Andaya CR; Gelber RH
Lepr Rev; 2011 Sep; 82(3):253-8. PubMed ID: 22125933
[TBL] [Abstract][Full Text] [Related]
20. Treatment of leprosy.
Kar HK; Gupta R
Clin Dermatol; 2015; 33(1):55-65. PubMed ID: 25432811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
